|
Gene Information
|
Gene Name
|
MET |
|
Gene ID
|
4233
|
|
Gene Full Name
|
MET proto-oncogene, receptor tyrosine kinase |
|
Gene Alias
|
HGFR; AUTS9; RCCP2; c-Met; DFNB97 |
|
Transcripts
|
ENSG00000105976
|
|
Virus
|
HBV |
|
Gene Type
|
protein coding |
|
HPA Location Info
|
Cytosol;Plasma membrane;Predicted to be secreted;
|
|
Membrane Info
|
Predicted membrane proteins |
|
HPA Protein Class Info
|
Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins |
|
Gene Function
|
Oncogene
|
|
Uniport_ID
|
P08581
|
|
HGNC ID
|
HGNC:7029
|
|
VEGA ID
|
OTTHUMG00000023299
|
|
OMIM ID
|
164860 |
|
String ID
|
9606.ENSP00000317272
|
|
Drugbank ID
|
BE0000915
|
|
Drug (Cytoscape Annotation)
|
Axitinib;Crizotinib |
|
PharmGKB ID
|
PA30763
|
|
FDA Approved Drug
|
Cabozantinib;Crizotinib;Capmatinib |
Target gene [MET] related to VISs
| DVID |
Chromosome |
HM |
TFBS |
CA |
Sum of Overlapped Records |
Detail |
| 1009612 |
chr7 |
1 |
14 |
|
15 |
View |
Relationship between gene expression and immune infiltrating cell level
| Data ID |
Disease |
Sample number |
Sample type |
|
LIHC (TCGA) |
Liver hepatocellular carcinoma |
424 |
Liver hepatocellular carcinoma HCV (HBV+)(86), Liver hepatocellular carcinoma HCV (HBV-)(19), Liver hepatocellular carcinoma (HBV+)(209), Liver hepatocellular carcinoma (HBV+)(60), Paracancerous HCV (HBV+)(4), Paracancerous (HBV-)(28), Paracancerous (HBV+)(18) |
> Dataset: LIHC
|
|
HeatMap of cell type fractions in all samples
|
Lollipop of MET expression and immune infiltrating cell level correlation result in HBV+ samples
|
MET expression: Low -> High
|
|
|
|
|